Barclays PLC Morphic Holding, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$26.12 - $34.07 $1.15 Million - $1.5 Million
44,039 Added 98.46%
88,766 $3.03 Million
Q1 2024

May 15, 2024
SELL
$26.64 - $40.31 $2.28 Million - $3.45 Million
-85,660 Reduced 65.7%
44,727 $1.58 Million
Q4 2023

Feb 15, 2024
BUY
$19.95 - $31.0 $1.12 Million - $1.75 Million
56,389 Added 76.2%
130,387 $3.77 Million
Q3 2023

Nov 07, 2023
BUY
$21.33 - $59.42 $149,395 - $416,177
7,004 Added 10.45%
73,998 $1.7 Million
Q2 2023

Aug 03, 2023
BUY
$34.33 - $62.11 $1.23 Million - $2.22 Million
35,718 Added 114.2%
66,994 $3.84 Million
Q1 2023

May 04, 2023
SELL
$26.01 - $48.69 $810,263 - $1.52 Million
-31,152 Reduced 49.9%
31,276 $1.18 Million
Q4 2022

Feb 13, 2023
BUY
$24.14 - $30.37 $78,696 - $99,006
3,260 Added 5.51%
62,428 $1.67 Million
Q3 2022

Nov 03, 2022
BUY
$22.23 - $33.37 $1.29 Million - $1.93 Million
57,877 Added 4483.11%
59,168 $1.68 Million
Q2 2022

Aug 12, 2022
SELL
$19.74 - $43.01 $45,856 - $99,912
-2,323 Reduced 64.28%
1,291 $28,000
Q1 2022

May 16, 2022
SELL
$36.25 - $52.02 $800,073 - $1.15 Million
-22,071 Reduced 85.93%
3,614 $145,000
Q4 2021

Feb 14, 2022
BUY
$43.27 - $65.72 $698,767 - $1.06 Million
16,149 Added 169.35%
25,685 $1.22 Million
Q3 2021

Nov 09, 2021
BUY
$53.61 - $67.5 $214,011 - $269,460
3,992 Added 72.01%
9,536 $540,000
Q2 2021

Aug 13, 2021
SELL
$45.13 - $64.99 $275,293 - $396,438
-6,100 Reduced 52.39%
5,544 $318,000
Q1 2021

May 13, 2021
BUY
$29.77 - $84.85 $212,766 - $606,422
7,147 Added 158.93%
11,644 $737,000
Q4 2020

Feb 11, 2021
SELL
$25.66 - $34.55 $45,854 - $61,740
-1,787 Reduced 28.44%
4,497 $151,000
Q3 2020

Nov 12, 2020
SELL
$22.51 - $30.11 $28,092 - $37,577
-1,248 Reduced 16.57%
6,284 $172,000
Q2 2020

Aug 12, 2020
BUY
$12.65 - $29.57 $50,258 - $117,481
3,973 Added 111.63%
7,532 $203,000
Q1 2020

May 13, 2020
SELL
$10.84 - $20.85 $15,024 - $28,898
-1,386 Reduced 28.03%
3,559 $52,000
Q4 2019

Feb 10, 2020
BUY
$13.02 - $19.5 $30,050 - $45,006
2,308 Added 87.52%
4,945 $85,000
Q3 2019

Nov 14, 2019
BUY
$17.46 - $29.05 $46,042 - $76,604
2,637 New
2,637 $48,000

Others Institutions Holding MORF

# of Institutions
8
Shares Held
4.7M
Call Options Held
0
Put Options Held
0
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email